Israeli biotech Pepticom (reported here previously) has raised $2.6 million to establish a company that can treat SARS-Cov-2 and its mutations. It will implement AI technology to design, discover and develop novel peptide molecules.
https://www.calcalistech.com/ctech/articles/0,7340,L-3897696,00.html